MCQ – 84428

A 33-year-old female with heavy menstrual bleeding for 6 months, no abnormalities on examination, and a normal ultrasound (USG) was initially treated with non-hormonal therapy, but it failed. What is the next management step?

Correct Answer » A Explanation

–Detailed Explanation:

Clinical Reasoning for the Correct Answer:
– Non-hormonal therapy (e.g., tranexamic acid, NSAIDs) is first-line for menorrhagia without organic pathology.
– Failure of non-hormonal therapy warrants escalation to hormonal therapy as the next step.
– Patient is young (33 years), has normal physical and imaging findings, and no obvious contraindications to hormonal agents.

Why Option A is Correct:
– Hormonal therapy (combined oral contraceptives, levonorgestrel intrauterine system, progestins) is indicated after non-hormonal therapy failure in women with normal imaging and no structural abnormalities.
– Addresses altered endometrial function and provides effective menstrual regulation.

Why Option B is Incorrect:
– Endometrial sampling (e.g., biopsy) is primarily indicated for abnormal uterine bleeding with risk factors for endometrial pathology (age ≥ 45 or younger with risk factors such as obesity, anovulation, failed medical management, or persistent symptoms).
– At 33 years and with a normal ultrasound, malignancy is unlikely unless bleeding remains refractory on hormonal therapy.

Why Option C is Incorrect:
– Hysterectomy is a definitive (last-resort) procedure for refractory menorrhagia unresponsive to less invasive approaches or when malignancy is suspected/proven.
– Not indicated before failure of both medical therapies and less invasive surgical procedures, especially in young women desiring uterine conservation.

Why Option D is Incorrect:
– Uterine artery ligation is a surgical option for persistent, severe menorrhagia not responsive to multiple lines of medical therapy.
– Not an early step; reserved for refractory cases not amenable to less invasive options.